Podolski-Renić, A.; Chigriai, M.; Jovanović Stojanov, S.; Grozdanić, M.; Lupšić, E.; Nikolić, I.; Dragoj, M.; Dinić, J.; Pešić, M.
LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models. Pharmaceutics 2025, 17, 189.
https://doi.org/10.3390/pharmaceutics17020189
AMA Style
Podolski-Renić A, Chigriai M, Jovanović Stojanov S, Grozdanić M, Lupšić E, Nikolić I, Dragoj M, Dinić J, Pešić M.
LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models. Pharmaceutics. 2025; 17(2):189.
https://doi.org/10.3390/pharmaceutics17020189
Chicago/Turabian Style
Podolski-Renić, Ana, Margarita Chigriai, Sofija Jovanović Stojanov, Marija Grozdanić, Ema Lupšić, Igor Nikolić, Miodrag Dragoj, Jelena Dinić, and Milica Pešić.
2025. "LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models" Pharmaceutics 17, no. 2: 189.
https://doi.org/10.3390/pharmaceutics17020189
APA Style
Podolski-Renić, A., Chigriai, M., Jovanović Stojanov, S., Grozdanić, M., Lupšić, E., Nikolić, I., Dragoj, M., Dinić, J., & Pešić, M.
(2025). LB-100 Enhances Drugs Efficacy Through Inhibition of P-Glycoprotein Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models. Pharmaceutics, 17(2), 189.
https://doi.org/10.3390/pharmaceutics17020189
